Liao et al. demonstrated that treatment with the KDM4C inhibitor SD70 and the KDM4A/B inhibitor NSC636819 attenuated the expression of target genes induced by ARID3B (which promotes CRC stem cell-like features) [140]. Here, KDM4C is linked to colorectal carcinoma.